Harvard Medical School is re-evaluating rigid conflict-of-interest rules that aim to shield scientific research from corporate influence amid complaints by some professors that the restrictions slow the process of turning discoveries into research tools and treatments. Eric Campbell (Mass General), Donald Ingber (Wyss Institute), Marcia Angell (HMS) and Charles Serhan (Brigham and Women’s) are quoted.
Trending News
Research Provides Clues to Spleen’s Role in Coronary Artery Disease
Genetic variants may drive visible changes in the spleen that contribute to heart disease
Patient Who Received Pig Kidney Becomes First To Progress to Human Kidney Transplant
Study shows xenotransplantation can serve as a bridge for patients with end-stage kidney disease
Pilots, Flight Attendants Have Greater Risk of Radiation-Related Cancer Death Than Other Professions
Findings support efforts to protect U.S. aircrews from cosmic radiation exposure